about bcg-psn to combat age-related chronic bronchial asthma 19 cases(关于bcg-psn对抗老年性慢性支气管哮喘19例).docVIP

about bcg-psn to combat age-related chronic bronchial asthma 19 cases(关于bcg-psn对抗老年性慢性支气管哮喘19例).doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
about bcg-psn to combat age-related chronic bronchial asthma 19 cases(关于bcg-psn对抗老年性慢性支气管哮喘19例)

About BCG-PSN to combat age-related chronic bronchial asthma 19 cases : Wangfang Lian Li Hui Liu Mingxing Li Xiangdong [Keywords] chronic bronchial asthma Keywords: chronic bronchial asthma; elderly; BCG-PSN 1 Clinical data Are retired veterans and their families in treatment group, 19 patients, aged 67 to 79 (average 72.2 years old. Were 12 males and 7 females, duration 13 ~~ 30a which combined with 12 cases of chronic pulmonary heart disease, coronary heart disease 13 cases , diabetes control group of 12 patients, aged 67 to 79 (mean 73.3 years, duration of 11 ~~ 30a, 9 males and 3 females, which merged with chronic pulmonary heart disease and 10 cases, nine cases of coronary heart disease, diabetes three cases. selected cases based on history, clinical symptoms, signs and X-ray and the interests of the undertaking of second the National Asthma session revised diagnostic criteria (1996. treatment group taking conventional drugs (cough, and asthma, anti-infection, etc. CD Seoul injection (BCG polysaccharide nucleic acid, 0.5mL, im, every other day, 4mo course of treatment (11, 12 and February. conventional drug treatment in the control group on the use of Xi’an Antai Pharmaceutical Co., Ltd. production acute exacerbation of symptomatic treatment, after treatment in the two groups were observed clinical symptoms, chest X-ray, blood, lung function compared markedly: treatment during or after the end of treatment, asthma no longer attack or attack, but her condition significantly reduced, wheezing significantly shortened without medication can relieve itself; effective: treatment during or after the end of treatment, the reduced number of asthma attacks, seizures interval prolongation, mild symptoms soon after taking the drug can ease; invalid: during treatment or treatment after the end of the number of asthma attacks did not reduce, its extent is not mitigate attacks. observation: After a year and 4mo., only 60 times after the injection is Seoul, with a t

您可能关注的文档

文档评论(0)

jiupshaieuk12 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档